The Blood and Marrow Transplant Program at Northside Hospital is a collaboration between The Blood and Marrow Transplant Group of Georgia (BMTGA) and Northside Hospital.

For questions, call (404)-255-1930

Why Refer a Patient to the NSH-BMT Program?

 

NSH-BMT Program: A Leader in Hematopoietic Stem Cell Therapy

  • For the past eight consecutive years (2009-2016)* the Program’s related and unrelated allogeneic donor one year survival outcomes have been among the BEST in the country.
  • Provides compassionate and personalized care
  • Leading edge clinical research trials available so patients do not have to travel to receive treatment - Refer to Cooperative Group Affiliations
  • A BMTGA physician is on call 24 hours a day, 7 days a week. Please call (404-255-1930).’
  • Satisfaction survey results consistently above the 90th percentile for physician care, nursing care and overall hospital experience.**

Program Achievements:

 

The NSH–BMT Program meets criteria of an excellent transplant center.***

  • BMT physician team who have completed post-hematology/oncology fellowship training in hematopoietic stem cell transplantation
  • Highly trained BMT/Leukemia Team that includes a dedicated BMT health psychologist, social worker, clinical BMT PharmD.’s, nutritional services, physical therapy and chaplain services
  • State-of-the-Art facilities
  • Referring Physicians are Important Members of Our Team

    • NSH-BMT physicians will coordinate
      state-of-the-art pre - post transplant care
      with the referring physician.
    • All transplant patients are routinely discharged post - transplant to the care of their referring physician.
    • We believe the referring physician is an important partner in transitioning patients back to their families, community and a life of wellness.
  • Comprehensive quality management program
  • Among the BEST survival outcomes in United States
  • Access to Clinical Trials
  • Collaboration with Dana-Farber Cancer Institute on Innovative Research Partnership: This groundbreaking Blood Cancer Research Partnership (BCRP), dana-farber.org/BCRP, will bring clinical trial testing of innovative blood cancer therapies to community oncology settings across the country. NSH-BMT is one of ten sites who have been selected to participate in this prestigious partnership.
  • Only Core NCI BMT-CTN transplant center in the state of Georgia
  • NCI- NCORP: Northside Hospital Cancer Institute and Lewis Cancer and Research Pavilion have partnered with Georgia CORE to participate in NCORP. NCORP is a five year NCI grant which will provide cancer patients access to the latest NCI clinical trials in their local community.

*Reported outcome data from bethematch.org. This survival information includes only patients who received their first allogeneic transplant between January 1, 2012 and December 31, 2014 using unrelated or related donors, and who had reported follow-up. Final 2016 Transplant Center Specific Survival Report, December 12, 2016.

**According to the 2015 Press Ganey HCAHPS Regulatory Survey

***The American Society for Blood and Marrow Transplantation, (ASBMT-http://ASBMT.org), The Foundation for Cellular Therapy, (FACT- www.factwebsite.org) and the National Marrow Donor Program (NMDP- www.marrow.org), are three bone marrow transplant governing organizations that provides physicians, patients and family members with detailed information on how to identify an excellent transplant center; outstanding survival outcomes, experienced/ trained staff, comprehensive quality management program, and state-of- the-art facilities.